WHO ICTRP trial
Open Label Study of the Effect of Daily Treatment with MPC-7869 in Subjects with…
NL-OMON31593 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON31593 |
|---|---|
| Public title | Open Label Study of the Effect of Daily Treatment with MPC-7869 in Subjects with Dementia of the Alzheimer s Type. |
| Scientific title | Open Label Study of the Effect of Daily Treatment with MPC-7869 in Subjects with Dementia of the Alzheimer s Type. - Alzheimer's disease |
| Primary sponsor | Myriad Pharmaceuticals, Inc |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Phase | 3 |
| Countries | The Netherlands |
| Conditions | Alzheimer's disease Dementia;10012272;Alzheimer's disease;Dementia |
| Interventions | ;Alzheimer type.;Dementia |
| Registration date | Jul 30, 2008 |
| Target size | 11 |
| Secondary IDs | 2007-003362-17;NL20362.029.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: